18-02-2025, 18:00

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Notified -
Globe Newswire18-02-2025, 18:00
27-01-2025, 18:00

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

Notified -
Globe Newswire27-01-2025, 18:00